These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1209 related items for PubMed ID: 16315641
21. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J, Kumar S, Isenberg DA. Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [Abstract] [Full Text] [Related]
26. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Arnout J, Meijer P, Vermylen J. Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770 [Abstract] [Full Text] [Related]
27. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome. Hanly JG, Smith SA. J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227 [Abstract] [Full Text] [Related]
28. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Brenner B, Tavori S, Lerner M, Tatarsky I, Lorber M. Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904 [Abstract] [Full Text] [Related]
29. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T. Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107 [Abstract] [Full Text] [Related]
30. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N. Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [Abstract] [Full Text] [Related]
32. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Sahin M, Duzgun N, Tunc SE, Tutkak H. Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958 [Abstract] [Full Text] [Related]
34. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity--discrimination between functional and non-functional anti-prothrombin-antibodies. Horbach DA, van Oort E, Derksen RH, de Groot PG. Thromb Haemost; 1998 Apr; 79(4):790-5. PubMed ID: 9569194 [Abstract] [Full Text] [Related]
35. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B. Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898 [Abstract] [Full Text] [Related]
36. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA. Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928 [Abstract] [Full Text] [Related]